Cargando…

AZD9773 is a novel and potent anti-TNFα polyclonal ovine immune Fab

Detalles Bibliográficos
Autores principales:	Newham, P, Ceuppens, P, Davies, G, Growcott, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066935/ http://dx.doi.org/10.1186/cc9681

Ejemplares similares

Preclinical pharmacodynamics and safety profiling of AZD9773: a novel anti-TNFα polyclonal immune ovine Fab similar to D-CytoFab
por: Newham, P, et al.
Publicado: (2011)

Safety and tolerability of an ovine-derived polyclonal anti-TNFα Fab fragment (AZD9773) in patients with severe sepsis
por: Morris, P, et al.
Publicado: (2011)

AZD9773, a novel anti-TNFα immune Fab in development for severe sepsis and septic shock: demonstration of safety and efficacy in a murine CLP sepsis model
por: Newham, P, et al.
Publicado: (2011)

Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα
por: Abbott, W. Mark, et al.
Publicado: (2013)

P205: An outbreak of polyclonal pseudomonas aeruginosa bacteremia in hemodialysis patients
por: Ciobotaro, P, et al.
Publicado: (2013)

Antibacterial therapy in ovine model of sepsis
por: Nakano, Y, et al.
Publicado: (2006)

An ovine intensive care model of septic shock
por: Chapman, M, et al.
Publicado: (2010)

Relationship between polyclonal immunoglobulin therapy and colonization by Candida spp.
por: Serafini, G, et al.
Publicado: (2012)

Systematic profiling of polyclonal HIV antibodies and prediction of effector functions
por: Brown, E
Publicado: (2012)

Response of pediatric uveitis to TNFα inhibitors
por: Lerman, Melissa A, et al.
Publicado: (2012)

Monitoring of anti-TNF biological treatments
por: Ruiz del Agua, A, et al.
Publicado: (2010)

In vitro and in vivo determination of anti-TNFα activity in canine plasma from donors subject to preconditioning with endotoxin
por: Kotiw, Michael, et al.
Publicado: (2007)

Predictors of response and anti-TNF drugs comparative efficacy
por: Canhão, Helena, et al.
Publicado: (2011)

Igm-enriched polyclonal immunoglobulins in an experimental model of gram negative pneumonia developing septic shock
por: Vaschetto, R, et al.
Publicado: (2015)

Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
por: Tynjälä, P, et al.
Publicado: (2008)

Evaluation of FR104, a Treg sparing antagonist anti-CD28 monovalent Fab’ antibody in kidney transplantation in non-human primates
por: Poirier, Nicolas, et al.
Publicado: (2012)

Effects of neuronal nitric oxide synthase in ovine lung injury
por: Saunders, F, et al.
Publicado: (2007)

Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment
por: Vojinovic, J, et al.
Publicado: (2011)

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
por: Tarkiainen, M, et al.
Publicado: (2008)

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock
por: Morris, Peter E, et al.
Publicado: (2012)

Kinetics of TNF-α during continuous hemodiafiltration in patients with sepsis
por: Iakovleva, I, et al.
Publicado: (2004)

Detection of ovine herpesvirus-2 in swine semen, Brazil
por: Costa, Erica Azevedo, et al.
Publicado: (2010)

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab
por: Edgson, Lucy, et al.
Publicado: (2010)

Understanding the biology and use of anti-TNF agents in JIA – interim results
por: Lovell, Daniel J, et al.
Publicado: (2012)

Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
por: Sholukh, AM, et al.
Publicado: (2012)

Haemodynamic effects of clonidine in an ovine model of severe sepsis with septic acute kidney injury
por: Calzavacca, P, et al.
Publicado: (2014)

Regional perfusion and oxygenation of the kidney in an ovine model of severe sepsis with hypotension and kidney injury
por: Calzavacca, P, et al.
Publicado: (2012)

Ceftazidime reduces pulmonary hypertension in an ovine model of sepsis following smoke inhalation injury
por: Maybauer, DM, et al.
Publicado: (2005)

Modulation of peroxynitrite improves host response to vasopressin in ovine sepsis
por: Fujiwara, Osamu, et al.
Publicado: (2013)

Electron microscopic renal tubular injury score in ovine endotoxemia
por: Ertmer, C, et al.
Publicado: (2009)

Differential effect of alcohol on TNFα receptor II production in the presence of LPS challenge ex vivo
por: Gavala, A, et al.
Publicado: (2014)

Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
por: Espada, G, et al.
Publicado: (2011)

Haemodynamic and renal effects of clonidine in an ovine model of severe sepsis and septic acute kidney injury
por: Calzavacca, P, et al.
Publicado: (2012)

Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulins
por: Schieferdecker, Aneta, et al.
Publicado: (2016)

Drugs responsible of DRESS syndrome regulate IL-10 and TNF-α secretion
por: Calbo, Sébastien, et al.
Publicado: (2014)

Improving adoptive T cell therapy with adenoviruse armed with TNF-α and IL-2
por: Havunen, Riikka, et al.
Publicado: (2015)

Modeling sepsis induced by methicillin-resistant Staphylococcus aureus infection: a human/ovine approach
por: Schentag, JJ, et al.
Publicado: (2010)

Vasopressin and terlipressin as first-line therapy in fulminant ovine septic shock
por: Rehberg, S, et al.
Publicado: (2008)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6lcob49mators9buo36su5oku6